Login / Signup

Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.

Wei Yee ChanEmilie SanchezSelina J ChavdaCatherine S Y LecatLouise AinleyKe XuBrendan WisniowskiShameem MahmoodXenofon PapanikolaouCharalampia KyriakouJonathan SiveAshutosh WechalekarRakesh PopatNeil RabinLydia LeeEleni NastouliKwee L Yong
Published in: British journal of haematology (2021)
Keyphrases
  • sars cov
  • cell therapy
  • single cell
  • respiratory syndrome coronavirus
  • mesenchymal stem cells
  • coronavirus disease
  • replacement therapy